CIK 0001478320
- Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- Operating
- EIN
- 270907024
- Phone
- +1 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $14,724,890
- in 17 filings, $14.5M under 10b5-1 plans
Net −$14,724,890. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-21 | ROBINS HARLAN S Chief Scientific Officer | Exercise or conversion 10b5-1 | +284,800 | $6.55 | $1.9M | 1,304,458 |
| 2026-07-21 | ROBINS HARLAN S Chief Scientific Officer | Sale 10b5-1 | −278,698 | $21.72 | $6.1M | 1,025,760 |
| 2026-07-21 | ROBINS HARLAN S Chief Scientific Officer | Sale 10b5-1 | −213,702 | $22.12 | $4.7M | 812,058 |
| 2026-07-21 | ROBINS HARLAN S Chief Scientific Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −284,800 | 0 | ||
| 2026-07-02 | ROBINS HARLAN S Chief Scientific Officer | Sale 10b5-1 | −239,351 | $21.74 | $5.2M | 1,166,547 |
| 2026-07-02 | ROBINS HARLAN S Chief Scientific Officer | Sale 10b5-1 | −146,889 | $22.45 | $3.3M | 1,019,658 |
| 2026-06-16 | ROBINS HARLAN S Chief Scientific Officer | Sale 10b5-1 | −6,160 | $18.01 | $111K | 1,405,898 |
| 2026-06-15 | ROBINS HARLAN S Chief Scientific Officer | Sale 10b5-1 | −100,000 | $17.37 | $1.7M | 1,412,058 |
| 2026-04-08 | ROBINS HARLAN S Chief Scientific Officer | Sale 10b5-1 | −10,000 | $14.85 | $149K | 1,512,058 |
| 2026-03-11 | ROBINS HARLAN S Chief Scientific Officer | Sale | −140,666 | $13.17 | $1.9M | 1,851,658 |
| 2026-03-11 | ROBINS HARLAN S Chief Scientific Officer | Sale | −329,600 | $13.17 | $4.3M | 1,522,058 |
| 2026-03-06 | ROBINS HARLAN S Chief Scientific Officer | Grant or award | +709,220 | 1,992,324 | ||
| 2026-03-04 | ROBINS HARLAN S Chief Scientific Officer | Grant or award | +127,813 | 1,283,104 | ||
| 2026-03-03 | ROBINS HARLAN S Chief Scientific Officer | Sale 10b5-1 | −14,233 | $16.52 | $235K | 1,155,291 |
| 2026-03-02 | ROBINS HARLAN S Chief Scientific Officer | Sale 10b5-1 | −10,000 | $15.72 | $157K | 1,169,524 |
| 2026-02-03 | ROBINS HARLAN S Chief Scientific Officer | Sale 10b5-1 | −8,120 | $19.00 | $154K | 1,179,524 |
| 2026-02-02 | ROBINS HARLAN S Chief Scientific Officer | Sale 10b5-1 | −34,668 | $18.60 | $645K | 1,187,644 |
| 2026-01-06 | ROBINS HARLAN S Chief Scientific Officer | Sale 10b5-1 | −10,000 | $16.44 | $164K | 1,222,312 |
| 2025-12-04 | ROBINS HARLAN S Chief Scientific Officer | Sale 10b5-1 | −10,000 | $16.61 | $166K | 1,232,312 |
| 2025-12-03 | ROBINS HARLAN S Chief Scientific Officer | Sale 10b5-1 | −27,212 | $18.61 | $506K | 1,242,312 |
Page 1 of 16 · 318 trades